China Universal Asset Management Co., Ltd.
Position in LFCR — Lifecore Biomedical, Inc. \De\
CIK 1906594
SHANGHAI, F4
Position in LFCR
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$31,342
+$6,608 QoQ
Shares Held
5,970
-10.2% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 14 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LFCR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026China Universal Asset Management Co., Ltd. holds $16,477,419 across 28 Drug Manufacturers - Specialty & Generic names. LFCR ranks #28 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
6,755 | $3,660,061 | |
| 2 | VTRS |
Viatris Inc
|
185,339 | $2,943,183 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
16,003 | $2,697,145 | |
| 4 | ALKS |
Alkermes plc.
|
26,527 | $1,389,882 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
50,773 | $878,880 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
19,404 | $796,146 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
7,369 | $471,247 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
9,237 | $429,612 |
All Filings in LFCR
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,342 | 5,970 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $24,734 | 6,649 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $49,938 | 6,105 | Shares | Sole | 2026-01-29 | |
| No filing history on record for this holder in this stock. | ||||||